Since being founded by parents in 1960, Cystic Fibrosis Canada has dramatically changed the cystic fibrosis (CF) story.

Cystic Fibrosis Canada is a national not-for-profit corporation and one of the world’s top three charitable organizations committed to improving and lengthening the lives of people living with cystic fibrosis.

In their 60 year history, they have invested more than $260M in cystic fibrosis research and care that has more than doubled life expectancy for Canadians living with cystic fibrosis. Cystic Fibrosis Canada has contributed to the global body of CF knowledge, funding research achievements such as mapping the gene that causes cystic fibrosis, in 1989. And they have advanced access to life-changing CF medicines in Canada through relentless advocacy and government relations work.

Today, Cystic Fibrosis Canada is a leading organization with a central role engaging people living with cystic fibrosis, parents and caregivers, volunteers, researchers and healthcare professionals, government and donors. They work together to change lives through treatments, research, information and support.

Funding interests

Award types

Research Trainee


Research interests

  • cystic fibrosis
  • gene therapy
  • diabetes
  • lung inflammation
  • personalized medicine
  • proteins
  • quality of life
  • lung infections
  • clinical care
  • multidisciplinary care
  • antimicrobial resistance
  • AMR

Awards

2021

Recipient

Jonathan Rayment

Award type

Health Professional-Investigator award


Project title

Advanced pulmonary diagnostics in paediatric respiratory medicine: From technical development to clinical implementation

Recipient

Shekooh Behroozian

Award type

Research Trainee award


Project title

Development of a non-invasive diagnostic to detect bacterial pulmonary infections in patients with cystic fibrosis